01 / DESIGN
What was studied?
A small human analytical investigation used chromatography and high-resolution mass spectrometry to characterize several growth-hormone-releasing peptides and their urinary metabolites.
02 / FINDINGS
What did the researchers report?
Parent compounds and metabolites differed across peptides; ipamorelin underwent extensive metabolism, supporting compound-specific analytical targets.
03 / LIMITS
How should it be interpreted?
The work was designed for analytical detection, not treatment efficacy. Very small exposure groups cannot establish general pharmacokinetics, safety or a universal detection interval.
Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.